MusthInsider

Latest On GlycoMimetics, Inc (GLYC):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-30 15:17 EST	News	GlycoMimetics: Insider Buying Continues, And Chart Looks Healthy	N/A
2023-05-10 16:14 EST	News	GlycoMimetics: An Asymmetric Opportunity That Could Change Hematology	N/A
2023-05-04 00:06 EST	News	GlycoMimetics, Inc. (GLYC) Q1 2023 Earnings Call Transcript	N/A
2023-05-03 10:57 EST	News	GlycoMimetics GAAP EPS of -$0.17 in-line	N/A
2023-04-04 15:04 EST	News	GlycoMimetics Has Few Risks, Great Outlook In Leukemia	N/A
2023-03-29 13:01 EST	News	GlycoMimetics GAAP EPS of -$0.19 misses by $0.02	N/A
2023-03-29 13:00 EST	News	GlycoMimetics, Inc. (GLYC) Q4 2022 Earnings Call Transcript	N/A
2023-03-13 13:57 EST	News	RAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley Bank	N/A
2023-03-09 01:56 EST	News	GlycoMimetics: Stock Price Drop Brings Great Speculative Trade Opportunity	N/A
2023-02-22 13:21 EST	News	GlycoMimetics slips as chief scientific officer departs	N/A
2023-02-18 18:22 EST	News	Stocks To Watch: Retail Gets Tested With Walmart, Home Depot And CAGNY Conference On Tap	N/A
2023-02-17 16:57 EST	News	GlycoMimetics: Unraveling The Tea Leaves	N/A
2023-02-15 11:21 EST	News	GlycoMimetics sheds 39% after 11.8M stock offering	N/A
2023-01-03 16:22 EST	News	GlycoMimetics: A Cancer-Cure Lottery Ticket Grabbing My Attention	N/A
2022-11-12 05:25 EST	News	GlycoMimetics Could Surge If Q1 Data Readout Is Positive	N/A
2022-11-10 00:37 EST	News	GlycoMimetics GAAP EPS of -$0.16 beats by $0.10	N/A
2022-11-10 00:36 EST	News	GlycoMimetics, Inc. (GLYC) Q3 2022 Earnings Call Transcript	N/A
2022-09-06 09:09 EST	News	GlycoMimetics has a new Chief Medical Officer	N/A
2022-08-03 21:08 EST	News	GlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue of $75K	N/A
2022-08-03 21:07 EST	News	GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call Transcript	N/A
2022-04-30 17:59 EST	News	GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q1 2022 Results - Earnings Call Transcript	N/A
2022-04-28 13:35 EST	News	GlycoMimetics GAAP EPS of -$0.28 beats by $0.03	N/A
2022-04-27 22:51 EST	News	GlycoMimetics Q1 2022 Earnings Preview	N/A
2022-03-17 10:10 EST	News	GlycoMimetics Positive Data For AML Therapy Increasingly Likely	N/A
2022-03-17 10:09 EST	News	GlycoMimetics' Uproleselan: Secondary Reasons To Own The Stock	N/A
2022-03-04 23:25 EST	News	GlycoMimetics files for $250M mixed shelf offering	N/A
2022-03-03 12:03 EST	News	GlycoMimetics GAAP EPS of -$0.33 beats by $0.01, revenue of $0.18M	N/A
2022-03-03 12:02 EST	News	GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q4 2021 Results - Earnings Call Transcript	N/A
2022-03-02 17:47 EST	News	GlycoMimetics Q4 2021 Earnings Preview	N/A
2021-11-12 21:45 EST	News	GlycoMimetics A Buy On Nearing Trial Enrollment Completion	N/A
2021-11-02 16:41 EST	News	GlycoMimetics reports Q3 results	N/A
2021-11-02 16:40 EST	News	GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call Transcript	N/A
2021-11-01 20:02 EST	News	GlycoMimetics Q3 2021 Earnings Preview	N/A
2021-09-26 20:14 EST	News	GlycoMimetics (GLYC) Investor Presentation - Slideshow	N/A
2021-09-24 05:04 EST	News	GlycoMimetics shares jump 12% after highlighting promising data from uproleselan leukemia trial	N/A
2021-08-08 12:49 EST	News	GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2021 Results - Earnings Call Transcript	N/A
2021-08-06 03:42 EST	News	GlycoMimetics EPS beats by $0.03	N/A
2021-08-05 05:21 EST	News	GlycoMimetics names Harout Semerjian as chief executive officer	N/A
2021-07-23 00:09 EST	News	Treatment gets underway in early-stage leukemia trial of GlycoMimetics' uproleselan	N/A
2021-07-21 10:27 EST	News	GlycoMimetics says first patient dosed in investigator-sponsored mid-stage uproleselan study	N/A
2021-07-21 09:54 EST	News	Dosing gets underway in GlycoMimetics' uproleselan combination leukemia study	N/A
2021-05-03 23:14 EST	News	GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q1 2021 Results - Earnings Call Transcript	N/A
2021-03-04 11:44 EST	Analyst Rating	The Analyst Target Price has decreased from $10.5 to $10.25.	Neutral
2021-03-04 07:43 EST	Financials	Company financials have been released.	Neutral
2021-03-03 11:42 EST	Earnings Estimate	An EPS average of -$1.36 is estimated for the 2022 year.	Sell
2021-03-03 11:42 EST	Earnings Estimate	An EPS average of -$0.31 is estimated for the quarter ending on June 30, 2021.	Buy
2021-03-03 07:24 EST	News	GlycoMimetics, Inc.'s (GLYC) CEO Rachel King on Q4 2020 Results - Earnings Call Transcript	N/A
2021-03-02 13:01 EST	News	GlycoMimetics EPS in-line, misses on revenue	N/A
2021-02-23 14:50 EST	News	GlycoMimetics picks internal candidate for chief medical officer	N/A
2020-12-08 11:54 EST	Analyst Rating	The Analyst Target Price has increased from $9 to $10.5.	Buy

About GlycoMimetics, Inc (GLYC):

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease. It is also developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as Phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359 to target E-selectin and a chemokine receptors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin; and Galectin-3, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and collaboration and license agreement with Apollomics for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was founded in 2003 and is headquartered in Rockville, Maryland.

See Advanced Chart

General

Name GlycoMimetics, Inc
Symbol GLYC
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 54
Fiscal Year EndDecember
IPO Date2014-01-10
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://glycomimetics.com

Valuation

Price/Sales (Trailing 12 Mt.) 15.03
Price/Book (Most Recent Quarter) 1.34
Enterprise Value Revenue 3.72
Enterprise Value EBITDA 0.09

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$1.28
Next Year EPS Estimate -$1.40
Next Quarter EPS Estimate -$0.33
Operating Margin -507%
Return on Assets -21%
Return on Equity -36%
Revenue 10.16 million
Earnings Per Share -$1.28
Revenue Per Share $0.22
Gross Profit 10.16 million
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 177.14 million
EBITDA -59150020
Analyst Target Price $10.25
Book Value Per Share $2.62

Share Statistics

Shares Outstanding 51.49 million
Shares Float 31.78 million
% Held by Insiders 215%
% Held by Institutions 78.59%
Shares Short 1.07 million
Shares Short Prior Month 919111
Short Ratio 1.15
Short % of Float 4%
Short % of Shares Outstanding 2%

Technicals

Beta 2.4
52 Week High $5.19
52 Week Low $1.94
50 Day Moving Average 3.61
200 Day Moving Average 3.56

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

GlycoMimetics, Inc (GLYC) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

GlycoMimetics, Inc (GLYC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-02	$163000	-$0.32	-$0.32	0.62%
2020-09-30	2020-11-06	$N/A	-$0.29	-$0.32	8.43%
2020-06-30	2020-07-31	$N/A	-$0.32	-$0.37	13.51%
2020-03-31	2020-05-01	$N/A	-$0.18	-$0.29	37.93%
2019-12-31	2020-02-28	$N/A	-$0.34	-$0.35	3.41%
2019-09-30	2019-11-07	$N/A	-$0.31	-$0.41	23.46%
2019-06-30	2019-08-01	$N/A	-$0.37	-$0.37	0%
2019-03-31	2019-05-02	$N/A	-$0.33	-$0.36	7.3%
2018-12-31	2019-03-06	$N/A	-$0.32	-$0.31	-3.9%
2018-09-30	2018-11-02	$N/A	-$0.27	-$0.32	16.49%
2018-06-30	2018-08-09	$N/A	-$0.26	-$0.34	22.96%
2018-03-31	2018-05-03	$N/A	-$0.33	-$0.28	-17.86%
2017-12-31	2018-03-06	$N/A	-$0.27	-$0.25	-8.87%
2017-09-30	2017-11-08	$N/A	-$0.24	-$0.30	18.64%
2017-06-30	2017-08-03	$N/A	-$0.30	-$0.35	14.29%
2017-03-31	2017-05-08	$N/A	-$0.34	-$0.36	5.56%
2016-12-31	2017-03-01	$-500	-$0.36	-$0.36	0%
2016-09-30	2016-11-04	$19000	-$0.34	-$0.42	18.07%
2016-06-30	2016-08-04	$N/A	-$0.41	-$0.48	14.58%
2016-03-31	2016-05-04	$N/A	-$0.40	-$0.46	13.04%
2015-12-31	2016-02-29	$36000	-$0.47	-$0.47	0%
2015-09-30	2015-11-12	$-20035000	-$0.38	-$0.40	5%
2015-06-30	2015-08-06	$20.04 million	$0.51	-$0.40	227.5%
2015-03-31	2015-05-05	$N/A	-$0.37	-$0.37	0%
2014-12-31	2015-03-16	$15.03 million	-$0.39	-$0.22	-77.27%
2014-09-30	2014-10-31	$-15027000	-$0.35	$0.21	-266.67%
2014-06-30	2014-07-31	$15.03 million	$0.39	$0.24	62.5%
2014-03-31	2014-05-09	$23.59 million	-$0.30	-$0.30	0%

GlycoMimetics, Inc (GLYC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Research Development	11.72 million	10.67 million	N/A	N/A	11.47 million
Income Before Tax	-15.56 million	-13.72 million	N/A	N/A	-14.73 million
Selling General Administrative	4.01 million	4.06 million	N/A	N/A	3.87 million
Gross Profit	N/A	N/A	N/A	N/A	N/A
Ebit	-15.57 million	-13.73 million	N/A	N/A	-15.34 million
Operating Income	-15.57 million	-13.73 million	N/A	N/A	-15.34 million
Income Tax Expense	N/A	N/A	N/A	N/A	N/A
Total Revenue	163000	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Total Other Income Expense Net	N/A	N/A	N/A	N/A	608792
Net Income From Continuing Operations	-15.56 million	-13.72 million	N/A	N/A	-14.73 million
Net Income Applicable to Common Shares	-15.56 million	-13.72 million	-14.08 million	-7.66 million	-14.73 million

Cash Flow:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Investments	N/A	N/A	N/A	N/A	N/A
Change to Liabilities	89000	-1.77 million	1.7 million	28112	-1.62 million
Total Cash Flow from Investing Activities	-15813	-6383	-8136	-12357	-18266
Net Borrowings	N/A	N/A	N/A	N/A	N/A
Total Cash Flow from Financial Activities	4.55 million	N/A	N/A	119822	186770
Change to Operating Activities	N/A	-700824	409242	-49028	-391408
Change in Cash	-6.97 million	N/A	N/A	-12.69 million	-13.28 million
Total Cash from Operating Activities	-11.5 million	-14.55 million	-3.5 million	-12.79 million	-13.45 million
Depreciation	66527	N/A	N/A	67843	-233083
Other Cash Flow from Investing Activities	N/A	N/A	N/A	N/A	N/A
Change to Inventory	N/A	N/A	N/A	N/A	N/A
Change to Account Receivables	N/A	N/A	N/A	N/A	N/A
Other Cash Flow from Financing Activities	N/A	N/A	N/A	N/A	N/A
Change to Net Income	1.69 million	1.76 million	1.82 million	1.89 million	2.05 million
Capital Expenditures	15813	N/A	N/A	12357	18266

Balance Sheet:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Total Liabailities	14.61 million	12.15 million	N/A	N/A	13.77 million
Total Stockholder Equity	128.22 million	138.27 million	N/A	N/A	154.2 million
Other Current Liabilities	898549	874158	N/A	N/A	N/A
Total Assets	142.83 million	150.42 million	N/A	N/A	167.97 million
Common Stock	49018	47829	N/A	43581	43465
Other Current Assets	1.24 million	2.77 million	N/A	N/A	N/A
Retained Earnings	-309.47 million	-293.91 million	N/A	-266.11 million	-258.44 million
Other Liabilities	264329	N/A	N/A	393273	N/A
Other Assets	1.61 million	N/A	N/A	1.61 million	1.61 million
Cash	137.04 million	142.87 million	N/A	N/A	158.2 million
Total Current Liabilities	12.43 million	9.82 million	N/A	N/A	10.95 million
Other Stockholder Equity	N/A	N/A	N/A	N/A	N/A
Property, Plant & Equipment	620673	661541	N/A	3.6 million	3.83 million
Total Current Assets	138.27 million	145.64 million	N/A	N/A	162.53 million
Long Term Investments	N/A	N/A	N/A	N/A	N/A
Net Tangible Assets	128.22 million	138.27 million	148.49 million	148.49 million	154.2 million
Short Term Investments	N/A	N/A	N/A	N/A	N/A
Long Term Debt	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Payable	11.53 million	8.94 million	N/A	N/A	1.44 million

GlycoMimetics, Inc (GLYC) Chart:

GlycoMimetics, Inc (GLYC) News:

Below you will find a list of latest news for GlycoMimetics, Inc (GLYC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

GlycoMimetics, Inc (GLYC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2025-03-21	0.5	0.05	CALL	1	1872	290.36	FALSE	0	0
2025-03-21	1	0.05	CALL	0	177	341.13	FALSE	0	0
2025-03-21	1.5	0.05	CALL	0	31	405.31	FALSE	0	0
2025-03-21	2	0.53	CALL	0	32	539.84	FALSE	0	0
2025-03-21	2.5	0.1	CALL	0	8	0	FALSE	0	0
2025-03-21	5	0.1	CALL	0	9	568.77	FALSE	0	0
2025-03-21	7.5	0.1	CALL	0	116	617.6	FALSE	0	0
2025-03-21	0.5	0.25	PUT	3	103	299.14	TRUE	0.05	0.25
2025-03-21	1	0.05	PUT	0	34	440.66	TRUE	0	0
2025-03-21	1.5	1.16	PUT	0	14	0	TRUE	0	0
2025-03-21	2	0	PUT	0	0	0	TRUE	0	0
2025-03-21	2.5	0	PUT	0	0	0	TRUE	0	0
2025-03-21	5	0	PUT	0	0	0	TRUE	0	0
2025-03-21	7.5	0	PUT	0	0	917.8	TRUE	0	0
2025-04-17	0.5	0	CALL	0	0	0	FALSE	0	0
2025-04-17	1	0	CALL	0	0	0	FALSE	0	0
2025-04-17	1.5	0	CALL	0	0	0	FALSE	0	0
2025-04-17	2	0	CALL	0	0	321.7	FALSE	0	0
2025-04-17	2.5	0	CALL	0	0	344.15	FALSE	0	0
2025-04-17	5	0	CALL	0	0	409.01	FALSE	0	0
2025-04-17	7.5	0	CALL	0	0	444.16	FALSE	0	0
2025-04-17	0.5	0	PUT	0	0	217.53	TRUE	0	0
2025-04-17	1	0	PUT	0	0	873.93	TRUE	0	0
2025-04-17	1.5	0	PUT	0	0	0	TRUE	0	0
2025-04-17	2	0	PUT	0	0	0	TRUE	0	0
2025-04-17	2.5	0	PUT	0	0	0	TRUE	0	0
2025-04-17	5	0	PUT	0	0	0	TRUE	0	0
2025-04-17	7.5	0	PUT	0	0	682.83	TRUE	0	0
2025-06-20	0.5	0.13	CALL	0	1103	177.96	FALSE	0	0
2025-06-20	1	0.05	CALL	0	215	0	FALSE	0	0
2025-06-20	1.5	0.05	CALL	0	8	0	FALSE	0	0
2025-06-20	2	0.05	CALL	0	4	0	FALSE	0	0
2025-06-20	2.5	0.05	CALL	0	1	0	FALSE	0	0
2025-06-20	5	0.05	CALL	0	0	326.88	FALSE	0	0
2025-06-20	7.5	0.05	CALL	0	26	302.99	FALSE	0	0
2025-06-20	0.5	0.15	PUT	0	3	225.31	TRUE	0	0
2025-06-20	1	0.7	PUT	0	12	471.83	TRUE	0	0
2025-06-20	1.5	0	PUT	0	0	0	TRUE	0	0
2025-06-20	2	0	PUT	0	0	0	TRUE	0	0
2025-06-20	2.5	0	PUT	0	0	0	TRUE	0	0
2025-06-20	5	0	PUT	0	0	0	TRUE	0	0
2025-06-20	7.5	0	PUT	0	0	0	TRUE	0	0
2025-09-19	0.5	0.1	CALL	0	2239	160.87	FALSE	0	0
2025-09-19	1	0	CALL	0	0	185.55	FALSE	0	0
2025-09-19	1.5	0	CALL	0	0	0	FALSE	0	0
2025-09-19	2	0	CALL	0	0	0	FALSE	0	0
2025-09-19	2.5	0.05	CALL	0	60	267.92	FALSE	0	0
2025-09-19	5	0	CALL	0	0	0	FALSE	0	0
2025-09-19	7.5	0.01	CALL	0	31	0	FALSE	0	0
2025-09-19	0.5	0.24	PUT	0	14	118.06	TRUE	0	0
2025-09-19	1	0	PUT	0	0	233.03	TRUE	0	0
2025-09-19	1.5	0	PUT	0	0	0	TRUE	0	0
2025-09-19	2	0	PUT	0	0	0	TRUE	0	0
2025-09-19	2.5	0	PUT	0	0	0	TRUE	0	0
2025-09-19	5	0	PUT	0	0	0	TRUE	0	0
2025-09-19	7.5	0	PUT	0	0	0	TRUE	0	0

Latest GLYC Trades:

Date	Shares	Price
Jun 13, 2022 5:30 PM EST	100	$0.6216
Jun 13, 2022 6:41 PM EST	85	$0.6287
Jun 13, 2022 7:01 PM EST	100	$0.6216
Jun 13, 2022 7:58 PM EST	100	$0.6066
Jun 13, 2022 7:58 PM EST	100	$0.6066

GlycoMimetics, Inc (GLYC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm
2019-05-23	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1253689/000000000019008876/0000000000-19-008876-index.htm
2019-01-28	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000003877719000032/0000038777-19-000032-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000008025519002657/0000080255-19-002657-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000008025520001261/0000080255-20-001261-index.htm
2019-02-08	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000021545719006611/0000215457-19-006611-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000031506619001057/0000315066-19-001057-index.htm
2019-08-12	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000031506619001676/0000315066-19-001676-index.htm
2019-09-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000031506619001702/0000315066-19-001702-index.htm
2018-09-06	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000072888918001483/0000728889-18-001483-index.htm
2019-01-11	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000072888919000038/0000728889-19-000038-index.htm
2020-02-05	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000083423720005369/0000834237-20-005369-index.htm
2019-02-12	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000090221919000165/0000902219-19-000165-index.htm
2020-01-08	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000090221920000035/0000902219-20-000035-index.htm
2020-04-09	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000090221920000372/0000902219-20-000372-index.htm
2019-06-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000091420819000279/0000914208-19-000279-index.htm
2020-02-07	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000091420820000058/0000914208-20-000058-index.htm
2020-04-09	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000091420820000283/0000914208-20-000283-index.htm
2020-07-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000091420820000361/0000914208-20-000361-index.htm
2018-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000092189518000663/0000921895-18-000663-index.htm
2019-08-15	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002247/0000921895-19-002247-index.htm
2019-08-26	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002332/0000921895-19-002332-index.htm
2019-09-09	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002380/0000921895-19-002380-index.htm
2019-09-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000092189520000539/0000921895-20-000539-index.htm
2020-11-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2020-11-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2020-07-20	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000093583620000390/0000935836-20-000390-index.htm
2018-03-19	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1253689/000104746918001847/0001047469-18-001847-index.htm
2018-03-21	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1253689/000104746918001954/0001047469-18-001954-index.htm
2019-05-17	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1253689/000104746919003186/0001047469-19-003186-index.htm
2020-10-07	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1253689/000104746920005139/0001047469-20-005139-index.htm
2018-03-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000110465918019322/0001104659-18-019322-index.htm
2019-05-23	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1253689/000110465919031465/0001104659-19-031465-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000114420419008076/0001144204-19-008076-index.htm
2018-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118009860/0001209191-18-009860-index.htm
2018-05-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2018-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118031812/0001209191-18-031812-index.htm
2018-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118031817/0001209191-18-031817-index.htm
2018-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118031825/0001209191-18-031825-index.htm
2018-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118031836/0001209191-18-031836-index.htm
2018-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118031842/0001209191-18-031842-index.htm
2018-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118031858/0001209191-18-031858-index.htm
2018-05-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm
2018-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2018-10-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-11-28	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118060156/0001209191-18-060156-index.htm
2018-11-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919118060160/0001209191-18-060160-index.htm
2019-01-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119004821/0001209191-19-004821-index.htm
2019-01-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119004823/0001209191-19-004823-index.htm
2019-01-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119004825/0001209191-19-004825-index.htm
2019-01-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119004827/0001209191-19-004827-index.htm
2019-03-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119017473/0001209191-19-017473-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119031714/0001209191-19-031714-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119031716/0001209191-19-031716-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119031718/0001209191-19-031718-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119031720/0001209191-19-031720-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119031725/0001209191-19-031725-index.htm
2019-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119031734/0001209191-19-031734-index.htm
2019-08-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm
2019-08-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm
2019-12-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm
2020-01-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm
2020-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120004814/0001209191-20-004814-index.htm
2020-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120004818/0001209191-20-004818-index.htm
2020-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120004824/0001209191-20-004824-index.htm
2020-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120004826/0001209191-20-004826-index.htm
2020-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120004828/0001209191-20-004828-index.htm
2020-03-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032299/0001209191-20-032299-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032302/0001209191-20-032302-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032304/0001209191-20-032304-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032308/0001209191-20-032308-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032311/0001209191-20-032311-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm
2018-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000142573818000010/0001425738-18-000010-index.htm
2018-03-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018001530/0001558370-18-001530-index.htm
2018-03-06	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1253689/000155837018001553/0001558370-18-001553-index.htm
2018-03-06	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1253689/000155837018001557/0001558370-18-001557-index.htm
2018-04-13	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1253689/000155837018002958/0001558370-18-002958-index.htm
2018-05-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018003834/0001558370-18-003834-index.htm
2018-05-03	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837018003836/0001558370-18-003836-index.htm
2018-05-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018004900/0001558370-18-004900-index.htm
2018-07-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018005686/0001558370-18-005686-index.htm
2018-08-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837018006888/0001558370-18-006888-index.htm
2018-08-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018006892/0001558370-18-006892-index.htm
2018-11-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018008313/0001558370-18-008313-index.htm
2018-11-02	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837018008314/0001558370-18-008314-index.htm
2018-11-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837018009486/0001558370-18-009486-index.htm
2019-03-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019001513/0001558370-19-001513-index.htm
2019-03-06	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1253689/000155837019001537/0001558370-19-001537-index.htm
2019-03-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019001547/0001558370-19-001547-index.htm
2019-03-06	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1253689/000155837019001578/0001558370-19-001578-index.htm
2019-04-10	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1253689/000155837019002905/0001558370-19-002905-index.htm
2019-05-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019003802/0001558370-19-003802-index.htm
2019-05-02	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837019003803/0001558370-19-003803-index.htm
2019-05-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019005190/0001558370-19-005190-index.htm
2019-08-01	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837019006741/0001558370-19-006741-index.htm
2019-08-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019006743/0001558370-19-006743-index.htm
2019-08-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019007085/0001558370-19-007085-index.htm
2019-11-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837019010290/0001558370-19-010290-index.htm
2019-11-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019010292/0001558370-19-010292-index.htm
2019-11-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837019011165/0001558370-19-011165-index.htm
2020-01-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020000060/0001558370-20-000060-index.htm
2020-02-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020000636/0001558370-20-000636-index.htm
2020-02-28	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1253689/000155837020001723/0001558370-20-001723-index.htm
2020-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020001731/0001558370-20-001731-index.htm
2020-02-28	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1253689/000155837020001772/0001558370-20-001772-index.htm
2020-04-16	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1253689/000155837020003935/0001558370-20-003935-index.htm
2020-05-01	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837020004879/0001558370-20-004879-index.htm
2020-05-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020004881/0001558370-20-004881-index.htm
2020-05-08	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1253689/000155837020005890/0001558370-20-005890-index.htm
2020-05-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020006971/0001558370-20-006971-index.htm
2020-07-31	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837020008841/0001558370-20-008841-index.htm
2020-07-31	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020008848/0001558370-20-008848-index.htm
2020-10-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020011405/0001558370-20-011405-index.htm
2020-11-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1253689/000155837020013021/0001558370-20-013021-index.htm
2020-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1253689/000155837020013033/0001558370-20-013033-index.htm
2019-08-15	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1253689/000165495419009665/0001654954-19-009665-index.htm
2019-05-28	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1253689/999999999519001225/9999999995-19-001225-index.htm

GlycoMimetics, Inc (GLYC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GlycoMimetics, Inc (GLYC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 215%
Institutional Ownership: 7859%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2018-06-11	Brian M. Hahn	CFO	Sell	19,345.00	18.04	348,983.80	0.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2018-05-23	John L. Magnani	SVP of Research, CSO	Buy	1,491.00	0.33	492.03	100,793.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm
2019-08-13	DANIEL M JUNIUS	Director	Buy	10,000.00	3.18	31,800.00	18,000.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm
2019-12-20	John L. Magnani	SVP of Research, CSO	Buy	106,984.00	1.12	119,822.08	182,777.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm
2018-06-11	Brian M. Hahn	CFO	Buy	5,260.00	1.12	5,891.20	19,345.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2020-01-06	John L. Magnani	SVP of Research, CSO	Buy	106,983.00	1.12	119,820.96	289,760.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm
2019-09-05	PARTNERS L P/IL BVF	10% Share Holder	Buy	689,834.00	3.18	2,195,051.79	2,955,440.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2019-08-06	Rachel K. King	President, CEO	Buy	166,759.00	1.12	186,770.08	307,144.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm
2020-10-30	PARTNERS L P/IL BVF	10% Share Holder	Buy	250,755.00	2.75	689,576.25	3,206,195.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2019-09-05	PARTNERS L P/IL BVF	10% Share Holder	Buy	853,956.00	3.18	2,717,287.99	3,639,935.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-11-04	PARTNERS L P/IL BVF	10% Share Holder	Buy	506,155.00	2.60	1,316,003.00	3,712,350.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2020-03-09	DANIEL M JUNIUS	Director	Buy	20,000.00	3.40	68,000.00	38,000.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm
2020-10-30	PARTNERS L P/IL BVF	10% Share Holder	Buy	666,385.00	2.75	1,832,558.75	4,306,320.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2018-05-10	ENTERPRISE ASSOCIATES 10 L P NEW	10% Share Holder	Sell	4,006.00	17.81	71,346.86	4,702,791.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-10	M JAMES BARRETT	Director	Sell	4,006.00	17.81	71,346.86	4,702,791.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-10	PETER J BARRIS	10% Share Holder	Sell	4,006.00	17.81	71,346.86	4,702,791.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-10	SCOTT D SANDELL	10% Share Holder	Sell	4,006.00	17.81	71,346.86	4,702,791.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2020-11-04	PARTNERS L P/IL BVF	10% Share Holder	Buy	674,492.00	2.60	1,753,679.20	4,980,812.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2018-05-10	ENTERPRISE ASSOCIATES 10 L P NEW	10% Share Holder	Sell	5,533.00	17.81	98,542.73	4,995,664.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-10	M JAMES BARRETT	Director	Sell	5,533.00	17.81	98,542.73	4,995,664.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-10	PETER J BARRIS	10% Share Holder	Sell	5,533.00	17.81	98,542.73	4,995,664.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-10	SCOTT D SANDELL	10% Share Holder	Sell	5,533.00	17.81	98,542.73	4,995,664.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2019-09-05	PARTNERS L P/IL BVF	10% Share Holder	Buy	124,956.00	3.18	397,609.99	528,891.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-10-30	PARTNERS L P/IL BVF	10% Share Holder	Buy	15,472.00	2.75	42,548.00	544,363.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2020-11-04	PARTNERS L P/IL BVF	10% Share Holder	Buy	86,090.00	2.60	223,834.00	630,453.00	https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2018-10-18	John L. Magnani	SVP of Research, CSO	Sell	3,527.00	14.02	49,448.54	75,793.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-10-17	John L. Magnani	SVP of Research, CSO	Sell	7,273.00	14.00	101,822.00	79,320.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-10-16	John L. Magnani	SVP of Research, CSO	Sell	14,200.00	14.01	198,942.00	86,593.00	https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm

GlycoMimetics, Inc

(NASDAQ:GLYC)